AIDE N, LABICHE A, HERLIN P, PACIENCIA M, POULAIN L, DUTOIT S, MONTRAVERS F, GAUDUCHON P, CHASLE J.
Usefulness of Automatic Quantification of Immunochemical Staining on Whole Tumor Sections for Correlation with Oncological Small Animal PET Studies: An Example with Cell Proliferation, Glucose Transporter 1 and FDG.
Mol Imaging Biol 2008;10(5):237-44.

AIDE N, POULAIN L, BRIAND M, DUTOIT S, ALLOUCHE S, LABICHE A, NGO-VAN DO A, NATAF V, BATALLA A, GAUDUCHON P, TALBOT JN, MONTRAVERS F.
Early evaluation of chemotherapy effects with longitudinal FDG small animal PET in human testicular cancer xenografts : early flare response does not reflect refractory disease.
European Journal of Nuclear Medicine and Molecular Imaging, 2008 (in press)

AIDE N, COSTO S, LHEUREUX S, ALLOUACHE N, BARDET S.
Ivory vertebra appearing photopenic on Tc-99m MDP bone scan: demonstration by SPECT/CT.
Clin Nucl Med 2008;33(7):479-81.

BARDET S, MALVILLE E, RAME JP, BABIN E, SAMAMA G, DE RAUCOURT D, MICHELS JJ, REZNIK  Y, HENRY-AMAR M.
Macroscopic lymph-node involvement and neck dissection predict lymph-node recurrence in papillary thyroid carcinoma.
Eur J Endocrinol 2008;158:551-560.

BELOT A, GROSCLAUDE P, BOSSARD N, JOUGLA E, BENHAMOU E, DELAFOSSE P, GUIZARD AV, MOLINIE F, DANZON A, BARA S, BOUVIER AM, TRETARRE B, BINDER-FOUCARD F, COLONNA M, DAUBISSE L, HEDELIN G, LAUNOY G, LE STANG N, MAYNADIE M, MONNEREAU A, TROUSSARD X, FAIVRE J, COLLIGNON A, JANORAY I, ARVEUX P, BUEMI A, RAVERDY N, SCHVARTZ C, BOVET M, CHERIE-CHALLINE L, ESTEVE J, REMONTET L, VELTEN M.
Cancer incidence and mortality in France over the period 1980-2005.
Rev Epidemiol Sante Publique 2008;56(3):159-75.

BILLET S, ABBAS I, LEGOFF J, VERDIN A, ANDRE V, LAFARGUE PE, HACHIMI A, CAZIER F, SICHEL F, SHIRALI P, GARCON G.
Genotoxic potential of Polycyclic Aromatic Hydrocarbons-coated onto airborne Particulate Matter (PM(2.5)) in human lung epithelial A549 cells.
Cancer Lett 2008;270(1):144-55.

BILLET S, ABBAS I, LEGOFF J, VERDIN A, ANDRE V, LAFARGUE PE, HACHIMI A, CAZIER F, SICHEL F, SHIRALI P, GARCON G.
Persistant organic pollutants-coated onto air pollution particulate matter (PM2.5): genotoxicity in human lung epithelial A549 cells.
OrganoHalogen Compounds, 2008, 70, 737-740

BONNET C, KRIEGER S, VEZAIN M, ROUSSELIN A, TOURNIER I, MARTINS A, BERTHET P, CHEVRIER A, DUGAST C, LAYET V, ROSSI A, LIDEREAU R, FREBOURG T, HARDOUIN A, TOSI M.
Screening BRCA1 and BRCA2 unclassified variants for splicing mutations using reverse transcription PCR on patient RNA and an ex vivo assay based on a splicing reporter minigene.
J Med Genet 2008;45(7):438-46.
FERME C, EGHBALI H, HENRY-AMAR M.
Chemotherapy plus Involved-Field Radiation in Early-Stage Hodgkin’s Disease.
N Engl J Med 2008;358:743 (letter reply).

FAVIER O, HEUTTE N, CARDE P, VAN’T VEER MB, ALERMAN BMP, NOORDIJK EM, THOMAS J, STAMATOULLAS-BASTARD A, TIRELLI U, RAEMAEKERS J.M.M., CREEMERS GJ, BRON D, EGHBALI H, BRICE P, LUGTENBURG PJ, SEBBAN C, VOILLAT L, CASANOVAS RO, FERME C, HENRY-AMAR M
Survival after Hodgkin’s Lymphoma: Causes of death and excess mortality in patients treated in eight consecutive trials by the European Organisation for Research and Treatment of Cancer (EORTC) Lymphoma Group and the Groupe d’Études des Lymphomes de l’Adulte.
Cancer 2008 (Sous presse).

GARSI J-P, SCHLUMBERGER M, RUBINO C, RICARD M, LABBE M, CECCARELLI C, SCHVARTZ C, HENRY-AMAR M, BARDET S, DE VATHAIRE F.
Therapeutic administration of 131I for differentiated thyroid cancer, radiation dose to ovaries and outcome of pregnancies.
J Nucl Med 2008;49:845-852.

HAAS RLM, GIRINSKY T, ALEMAN BMP, HENRY-AMAR M, DE BOER JP, DE JONG D.
Low dose involved field radiotherapy as an alternative treatment for nodular lymphocyte predominance hodgkin lymphoma.
Int J Radiat Oncol Biol Phys 2008 (Sous presse). 

HEYMAN L, KELLOUCHE S, FERNANDES J, DUTOIT S, POULAIN L, CARREIRAS F.
Vitronectin and Its Receptors Partly Mediate Adhesion of Ovarian Cancer Cells to Peritoneal Mesothelium in vitro.
Tumour Biol 2008;29(4):231-44.

LABICHE A, HEUTTE N, HERLIN P, CHASLE J, GAUDUCHON P, ELIE N.
Stromal compartment as a survival prognostic factor in advanced ovarian carcinoma
International Journal of Gynecological Cancer - July 2008 - in press.

LABICHE A., ELIE N., HERLIN P., DENOUX Y., CROUET H., HEUTTE N., JOLY F., HERON JF., GAUDUCHON P., HENRY-AMAR M.
Prognostic significance of tumour vascularisation on survival of patients with advanced ovarian carcinoma
Histology and Histopathology - september 2008 - in press

LEBAILLY P, BOUCHART V, BALDI I, LECLUSE Y, GISLARD A, MALAS J.-P.
Exposure to pesticides in open-field farming in France.
Accepté pour publication (octobre 2008) dans /Annals of Occupational Hygiene

LHOMME C, JOLY F, WALKER JL, LISSONI AA, NICOLETTO MO, MANIKHAS GM, BAEKELANDT MM, GORDON AN, FRACASSO PM, MIETLOWSKI WL, JONES GJ, DUGAN MH.
Phase III study of valspodar (PSC 833) combined with paclitaxel and carboplatin compared with paclitaxel and carboplatin alone in patients with stage IV or suboptimally debulked stage III epithelial ovarian cancer or primary peritoneal cancer.
J Clin Oncol 2008;26(16):2674-82.

PAGET V, LECHEVREL M, SICHEL F.
Acetaldehyde-induced mutational pattern in the tumour suppressor gene TP53 analyzed by use of a functional assay, the FASAY (Functional Analysis of Separated Alleles in Yeast).
Mutation Research, 2008,  652, 12-19. 

PAGET V, SICHEL F, GARON D, LECHEVREL M
Aflatoxin B1-induced TP53 mutational pattern in normal human cells using the FASAY (Functional Analysis of Separated Alleles in Yeast).
Mutation Research, 2008, 656, 55-61.

RACADOT S, MERCIER M, DUSSART S, DESSARD-DIANA B, BENSADOUN RJ, MARTIN M, MALAURIE E, FAVREL V, HOUSSET M, DURDUX C, JOURNEL C, CALAIS G, HUETt J, PILLET G, HENNEQUIN C, HADDAD E, DIANA C, BLASKA-JAULERRY B, HENRY-AMAR M, GEHANNO P, BAILLET F, MAZERON JJ.
Randomized clinical trial of post-operative radiotherapy versus concomitant carboplatin and radiotherapy for head and neck cancers with lymph node involvement.
Radiother Oncol 2008;87:164-172.

RICHARD E, HEUTTE N, BOUCHART V, GARON D.
Evaluation of fungal contamination and mycotoxin production in maize silage.
Animal Feed Science and Technology/ [sous presse].

ROUE G, PICHEREAU V, LINCET H, COLOMER D, SOLA B.
Cyclin D1 mediates resistance to apoptosis through upregulation of molecular chaperones and consequent redistribution of cell death regulators.
Oncogene 2008;27(36):4909-20.